GUCY2C and adenocarcinoma: These molecular alterations in intestinal epithelial stem cells are known to develop into metaplasia marked by higher expression of Guanylyl cyclase C (GUCY2C) [28,29,30], which is a premalignant condition that increases the risk of progression to dysplasia, adenoma, and adenocarcinoma [31,32].